EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Determining Good Candidates for Atrioventricular Junction Ablation and Device Therapy and Which Device to Implant

Arnaud Bisson iD, Thibaut Lenormand, Mathieu Jacobs iD, Laurent Fauchier iD

Arrhythmia & Electrophysiology Review · 22.12.2025

DOI: 10.15420/aer.2025.41 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arrhythmia & Electrophysiology Review, online erschienen am 22.12.2025. Verfasst von Arnaud Bisson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Service de Cardiologie, Centre Hospitalier Régional Universitaire et Faculté de Médecine de Tours Tours, France. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ‘ablate-and-pace’ strategy, combining atrioventricular junction ablation with permanent pacing, has re-emerged as a valuable therapeutic option for patients with AF who are symptomatic, have poor rate control or develop AF-mediated cardiomyopathy. While historically considered a last-resort treatment, recent randomised trials and meta-analyses support its efficacy in improving functional status, reducing hospitalisations and potentially enhancing survival, particularly when paired with CRT or conduction system pacing. The success of this approach depends on careful patient selection and appropriate device choice. Candidates include patients with uncontrolled ventricular rates, tachycardia–bradycardia syndrome, symptomatic bradycardia or those with poor CRT response due to persistent AF. Right ventricular pacing should be avoided when possible, in favour of biventricular or conduction system pacing, which preserves synchrony and reduces pacing-induced cardiomyopathy. This review discusses clinical scenarios, prognostic considerations, and current device options – including leadless systems – offering a practical guide for tailoring atrioventricular junction ablation-based therapies to individual patient profiles.

Schlagwörter

Stichwörter der Autor:innen

AFAtrioventricular junction ablationcardiac resynchronisation therapyconduction system pacingheart failure

Autor:innen und Institutionen

  • Service de Cardiologie, Centre Hospitalier Régional Universitaire et Faculté de Médecine de Tours Tours, France.
  • Inserm UMR1327 ISCHEMIA Membrane Signalling and Inflammation in Reperfusion Injuries, Université de Tours Tours, France.

ORCID-Profile: Arnaud Bisson, Mathieu Jacobs, Laurent Fauchier

Zitieren

APA

Bisson, A., Lenormand, T., Jacobs, M., & Fauchier, L. (2025). Determining Good Candidates for Atrioventricular Junction Ablation and Device Therapy and Which Device to Implant. Arrhythmia & Electrophysiology Review. https://doi.org/10.15420/aer.2025.41

Vancouver

Bisson A, Lenormand T, Jacobs M, Fauchier L. Determining Good Candidates for Atrioventricular Junction Ablation and Device Therapy and Which Device to Implant. Arrhythmia & Electrophysiology Review. 2025. doi:10.15420/aer.2025.41

BibTeX
@article{Bisson2025,
  author = {Bisson, Arnaud and Lenormand, Thibaut and Jacobs, Mathieu and Fauchier, Laurent},
  title = {Determining Good Candidates for Atrioventricular Junction Ablation and Device Therapy and Which Device to Implant},
  journal = {Arrhythmia & Electrophysiology Review},
  year = {2025},
  doi = {10.15420/aer.2025.41}
}
Kostenlos starten →